Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews · Wounds

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 3 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Laser therapy plus other treatment vs other treatment

Scar severity: Nd:YAG laser plus Diprospan plus 5‐FU versus Diprospan plus 5‐FU ‐ patient self‐assessment of scar improvement of 50% or higher ‐ keloid scars ‐ · participants with hypertrophic and keloid scars

It is very uncertain whether laser therapy plus other treatment changes scar severity: Nd:YAG laser plus Diprospan plus 5‐FU versus… compared with other treatment (very low certainty).

1 finding from 1 review

Laser therapy for treating hypertrophic and keloid scars 2022 · Cochrane Headline outcomes only
RR 1.38 [0.91, 2.1]
Studies not reported
Very low

Laser therapy plus other treatment vs other treatment

Incidence and severity of treatment‐related adverse effects: Nd:YAG laser plus Diprospan plus 5‐FU versus Diprospan plus 5‐FU ‐ keloid scars ‐ · participants with hypertrophic and keloid scars

1 finding from 1 review

Laser therapy for treating hypertrophic and keloid scars 2022 · Cochrane Headline outcomes only
7
Studies not reported
Very low

Laser therapy plus other treatment vs other treatment

Scar severity ‐ Neodymium‐doped yttrium aluminium garnet (Nd:YAG) laser plus Diprospan plus 5‐FU versus Diprospan plus 5‐FU ‐ blinded observer assessment of good to excellent scar improvement ‐ keloid scars ‐ · participants with hypertrophic and keloid scars

It is very uncertain whether laser therapy plus other treatment changes scar severity ‐ Neodymium‐doped yttrium aluminium garnet (Nd:YAG)… compared with other treatment (very low certainty).

1 finding from 1 review

Laser therapy for treating hypertrophic and keloid scars 2022 · Cochrane Headline outcomes only
RR 1.45 [0.88, 2.41]
Studies not reported
Very low